Tagged CT-152


Pharma and digital firms collaborate to develop MDD treatment

Pharmaceutical company Otsuka America and software treatment firm Click Therapeutics have reached a collaboration agreement to develop and commercialise a prescription digital therapeutic treatment for Major Depressive Disorder (MDD). The collaboration combines Click’s work in discovering and validating software applications and Otsuka’s in developing prescription therapies for patients with mental illness. The companies aim to…

© 2019 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.

Privacy policy

Terms and conditions